Channel Therapeutics Corporation
USD1.35
+0.09 (+7.14%)
CEO
Francis Knuettel II,
IPO Date
2024-02-16
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Open
$1.25
Prev. Close
$1.26
Day Low
$1.23
Day High
$1.48
52W Low
$1.23
52W High
$54.29
Market Cap
$0.01B
Volume
0.19M
| -4.5 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 114.5% | -7657.1% | -0.20 | 0.01 | -37.5 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 66.3% | -4464.2% | -0.15 | 0.01 | -112.6 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 16.2% | 0.0% | -0.30 | 0.00 | -465.0 |
| 31 Dec 2020 | FY | 30.7% | -330.4% | 18.5% | -919.1% | -0.07 | 0.02 | -419.1 |
| -4.8 |
| 30 Sept 2025 | Q3 | 0.0% | -219.3% | -27.9% | -12.8% | 0.05 | 2.01 | -1.0 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | 53.1% | -419.1% | -0.35 | 0.11 | -0.6 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 46.9% | -215.9% | -0.60 | 0.18 | -11.1 |
| 31 Dec 2024 | Q4 | 50.0% | -206.5% | 71.0% | -140.7% | -0.81 | 0.34 | -4.7 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | 118.7% | -79.2% | -1.60 | 0.60 | -6.1 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 970.6% | -68.0% | -8.70 | 0.93 | -10.2 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -226.7% | -63.6% | 0.00 | 1.39 | -13.4 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 62.7% | -4190.4% | -0.20 | 0.01 | -17.5 |